Aflokwalona

Potent photosensitizer - sun/UV exposure can precipitate severe dermatitis; cover skin and use high-SPF sunscreen. Marked ataxia and motor incoordination appear at higher doses with increased risk of falls. Mixing with any other CNS depressant markedly increases risk of respiratory depression. Limited clinical experience; purity of research chemical material is often uncertain - always reagent-test and start with an allergy dose of 1-5 mg. Fatal overdoses are rare but possible; naloxone is NOT effective - treat like barbiturate poisoning with airway management and supportive care.

Also known as: Aroft, Hq-495, Arofuto, Afloqualon, Aflocualona

Classification

Chemical: Quinazolinone
Psychoactive: Depressant
Tag: GABAergic
Tag: Habit-Forming
Tag: Research-Chemical
Tag: Sedative
Tag: Tentative

Effects

Muscle Relaxation
Sedation
Physical Euphoria
Respiratory Depression
Anxiolytic
Sedative
Anxiety Suppression
Motor Control Loss
Amnesia
Thought Deceleration
Dream Potentiation
Euphoria
Disinhibition
Blurred Vision
Dulled Perception
Tactile Enhancement
Open Eye Visuals
Increased Libido

Routes of Administration

Oral

Dosage

Threshold: 25 mg
Light: 50-75 mg
Common: 75-125 mg
Strong: 100-200 mg
Heavy: 200 mg+

Duration

Onset: 0.5-1.5 h
Peak: 1.5-3 h
Offset: 2-4 h
After Effects: 2-6 h
Total Duration: 4-8 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu